A novel family of retroviral vectors for the rapid production of complex stable cell lines.

The production of stable cell lines is an important technique in cell biology, and it is often the rate-limiting step in studies involving the characterization of the function of novel genes or gene mutations. To facilitate this process, a novel family of retroviral vectors, the pE vector family, has been generated. The retroviral sequences in the pE vectors have been taken from the Moloney murine leukemia virus (MMLV) vector pMFG, which has been shown to express cDNA inserts more consistently and at higher levels than earlier generations of MMLV vectors. These vectors contain four different internal ribosome entry site-selectable markers, allowing high-efficiency selection of transductants expressing the desired cDNA. The pE vectors have an episomal design to allow long-term production of high-titer virus without the need for subcloning the producer line. Using a strategy of combinatorial infection followed by combinatorial drug selection, we demonstrate that the pE vectors can be used to generate stable, polyclonal cell lines expressing at least three novel cDNAs in less than 2 weeks. The use of these vectors will thus dramatically accelerate the production of complex stable cell lines.

[1]  J. Yates,et al.  The Minimal Replicator of Epstein-Barr VirusoriP , 2000, Journal of Virology.

[2]  F. Pedersen,et al.  Expression of heterologous genes from an IRES translational cassette in replication competent murine leukemia virus vectors. , 1999, Gene.

[3]  G. Dickson,et al.  Construction and characterization of polycistronic retrovirus vectors for sustained and high-level co-expression of apolipoprotein A-I and lecithin-cholesterol acyltransferase. , 1999, Atherosclerosis.

[4]  P. Marrack,et al.  Live cell fluorescence imaging of T cell MEKK2: redistribution and activation in response to antigen stimulation of the T cell receptor. , 1999, Immunity.

[5]  I. Roninson,et al.  Internal ribosomal entry site-containing retroviral vectors with green fluorescent protein and drug resistance markers. , 1998, Human gene therapy.

[6]  M. Saleh A retroviral vector that allows efficient co-expression of two genes and the versatility of alternate selection markers. , 1997, Human gene therapy.

[7]  M. Pyron,et al.  A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo. , 1996, Human gene therapy.

[8]  R. Naviaux,et al.  The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses , 1996, Journal of virology.

[9]  F. Wurm,et al.  Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. , 1996, Nucleic acids research.

[10]  G. Nolan,et al.  Applications of retrovirus-mediated expression cloning. , 1996, Experimental hematology.

[11]  G. Forni,et al.  Co‐expression of B7‐1 and ICAM‐1 on tumors is required for rejection and the establishment of a memory response , 1995, European journal of immunology.

[12]  Sugimoto,et al.  Coexpression of a multidrug-resistance gene (MDR1) and herpes simplex virus thymidine kinase gene as part of a bicistronic messenger RNA in a retrovirus vector allows selective killing of MDR1-transduced cells , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  J. Sanes,et al.  The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos , 1991, Molecular and cellular biology.

[14]  H. Reiser sgp-60, a signal-transducing glycoprotein concerned with T cell activation through the T cell receptor/CD3 complex. , 1990, Journal of immunology.

[15]  G P Nolan,et al.  High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. , 1998, Cancer research.

[16]  E. Coligan Current protocols in immunology , 1991 .

[17]  J. Yates,et al.  Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells , 1985, Nature.